Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

One visit, two vaccines: study shows kids can safely get HPV and COVID shots together

NCT ID NCT05119855

Vaccine Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving the HPV vaccine and the Moderna COVID-19 vaccine at the same time is safe and works well for children aged 9 to 11. About 165 boys and girls took part. The researchers compared kids who got both vaccines on the same day to those who got them on different days. The goal was to see if the combination approach produced a strong immune response without extra side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

165 people

The number who actually took part.

Started

Mar 2022

Finished

Dec 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 11 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Has not yet had coitarche and does not plan on becoming sexually active during the vaccination period * Participant or participant's legally acceptable representative can read, understand, and complete the electronic vaccination report card (eVRC). Exclusion Criteria: * Known allergy to any vaccine component * History of severe allergic reaction that required medical intervention * Thrombocytopenia or any coagulation disorder * Has a history of myocarditis or pericarditis * Has a history of a clinical or microbiological diagnosis of COVID-19 ≤90 days prior to Day 1 visit or history of multisystem inflammatory syndrome in children (MIS-C) at any time prior to Day 1 visit * Females only: participant is pregnant * Currently immunocompromised, or been diagnosed with immunodeficiency * Had a splenectomy * Receiving or has received immunosuppressive therapies within the last year * Received any immunoglobulin product or blood-derived product within 3 months * Received a marketed HPV vaccine or has participated in an HPV vaccine clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronavirus disease (COVID-19) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19 prevention target human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronavirus disease (COVID-19) Papillomavirus infections

Contacts and locations

Locations

  • Accel Research Sites-DeLand Clinical Research Unit ( Site 0066)

    DeLand, Florida, 32720, United States

  • Acevedo Clinical Research Associates ( Site 0001)

    Miami, Florida, 33142, United States

  • Advanced Research For Health Improvement LLC ( Site 0075)

    Naples, Florida, 34102, United States

  • Advanced Research for Health Improvement, LLC ( Site 0012)

    Immokalee, Florida, 34142, United States

  • Alpha Science Research ( Site 0067)

    Miami, Florida, 33186, United States

  • Ark Clinical Research ( Site 0098)

    Long Beach, California, 90815, United States

  • Ark Clinical Research ( Site 0108)

    Tustin, California, 92780, United States

  • Atlanta Center for Medical Research ( Site 0055)

    Atlanta, Georgia, 30331, United States

  • CBH Health ( Site 0019)

    Gaithersburg, Maryland, 20877, United States

  • Carolina Institute for Clinical Research, LLC ( Site 0042)

    Fayetteville, North Carolina, 28303, United States

  • Certified Research Associates ( Site 0090)

    Cortland, New York, 13045, United States

  • Children's Clinic of Jonesboro, PA ( Site 0044)

    Jonesboro, Arkansas, 72401, United States

  • Clinical Research Prime ( Site 0088)

    Idaho Falls, Idaho, 83404, United States

  • Coast Clinical Research, LLC ( Site 0027)

    Bellflower, California, 90706, United States

  • Cognitive Clinical Trials, LLC ( Site 0054)

    Phoenix, Arizona, 85044, United States

  • Comprehensive Clinical Research ( Site 0038)

    West Palm Beach, Florida, 33409, United States

  • Corning Center for Clinical Research ( Site 0091)

    Horseheads, New York, 14845, United States

  • Dayton Clinical Research ( Site 0028)

    Dayton, Ohio, 45409, United States

  • DermResearch, Inc. ( Site 0056)

    Austin, Texas, 78759, United States

  • Eclipse Clinical Research ( Site 0095)

    Tucson, Arizona, 85745, United States

  • Emerson Clinical Research Institute ( Site 0021)

    Washington D.C., District of Columbia, 20011, United States

  • M3 Wake Research, Inc. ( Site 0014)

    Raleigh, North Carolina, 27612, United States

  • Medical Center for Clinical Research ( Site 0051)

    San Diego, California, 92120, United States

  • Midwest Children's Health Research Institute ( Site 0003)

    Lincoln, Nebraska, 68505, United States

  • Milton Haber, M.D. ( Site 0069)

    Laredo, Texas, 78041, United States

  • Mount Vernon Clinical Research ( Site 0053)

    Sandy Springs, Georgia, 30328, United States

  • Next Level Urgent Care, LLC ( Site 0099)

    Houston, Texas, 77057, United States

  • Preferred Research Partners Inc. ( Site 0092)

    Little Rock, Arkansas, 72211, United States

  • SKY Integrative Medical Center/SKYCRNG ( Site 0084)

    Ridgeland, Mississippi, 39157, United States

  • South Texas Clinical Research ( Site 0024)

    Corpus Christi, Texas, 78404, United States

  • South Texas Pediatric Research Group ( Site 0094)

    Del Rio, Texas, 78840, United States

  • Thomas Jefferson University - Family and Community Medicine ( Site 0006)

    Philadelphia, Pennsylvania, 19107, United States

  • University of Texas Medical Branch ( Site 0026)

    League City, Texas, 77573, United States

  • University of Utah ( Site 0076)

    Salt Lake City, Utah, 84132, United States

  • Valley Clinical Trials Inc. ( Site 0004)

    Northridge, California, 91325, United States

  • Velocity Clinical Research, Salt Lake City ( Site 0025)

    West Jordan, Utah, 84088, United States

  • WR-ClinSearch ( Site 0049)

    Chattanooga, Tennessee, 37421, United States

  • West Houston Clinical Research Services ( Site 0078)

    Houston, Texas, 77055, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.